LISTEN LIVE

cancer vaccine

Two researchers stand in front of the glass panels shielding their lab.
Daylina Miller / WUSF Public Media

The first human clinical trial is underway at Moffitt Cancer Center with what researchers are calling a "cancer vaccine."

Health News Florida's Daylina Miller spoke with Patricia Lawman, the co-founder of Tampa-based Morphogenesis. The immunotherapy company developed the vaccine, which is injected into cancer patients to help their immune systems identify and destroy tumors. 

The Phase I clinical trial for the vaccine, called ImmuneFX, is being tested on patients with severe cutaneous melanoma.

Two researchers stand in front of the glass panels shielding their lab.
Daylina Miller / WUSF Public Media

The first human clinical trial is underway at Moffitt Cancer Center with what researchers are calling a "cancer vaccine."

An experimental vaccine could be on the market for ovarian-cancer patients as soon as 2022, according to the Jacksonville-based company that makes it.

The River City’s Mayo Clinic is participating in the trials.